Catalyst Pharmaceuticals Inc (CPRX)
15.34
-0.66
(-4.12%)
USD |
NASDAQ |
Apr 18, 16:00
15.34
0.00 (0.00%)
Pre-Market: 08:54
Catalyst Pharmaceuticals Cash from Operations (TTM): 143.60M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 143.60M |
| September 30, 2023 | 128.03M |
| June 30, 2023 | 124.20M |
| March 31, 2023 | 119.64M |
| December 31, 2022 | 116.05M |
| September 30, 2022 | 95.15M |
| June 30, 2022 | 75.55M |
| March 31, 2022 | 65.04M |
| December 31, 2021 | 60.37M |
| September 30, 2021 | 54.30M |
| June 30, 2021 | 44.04M |
| March 31, 2021 | 41.64M |
| December 31, 2020 | 45.03M |
| September 30, 2020 | 44.22M |
| June 30, 2020 | 49.03M |
| March 31, 2020 | 49.84M |
| December 31, 2019 | 34.61M |
| September 30, 2019 | 13.97M |
| June 30, 2019 | -9.247M |
| March 31, 2019 | -28.08M |
| December 31, 2018 | -26.15M |
| September 30, 2018 | -21.83M |
| June 30, 2018 | -17.51M |
| March 31, 2018 | -15.95M |
| December 31, 2017 | -13.74M |
| Date | Value |
|---|---|
| September 30, 2017 | -14.12M |
| June 30, 2017 | -14.77M |
| March 31, 2017 | -15.91M |
| December 31, 2016 | -17.96M |
| September 30, 2016 | -18.18M |
| June 30, 2016 | -20.25M |
| March 31, 2016 | -20.15M |
| December 31, 2015 | -18.02M |
| September 30, 2015 | -17.36M |
| June 30, 2015 | -15.57M |
| March 31, 2015 | -14.31M |
| December 31, 2014 | -12.94M |
| September 30, 2014 | -13.09M |
| June 30, 2014 | -11.22M |
| March 31, 2014 | -10.05M |
| December 31, 2013 | -9.876M |
| September 30, 2013 | -7.339M |
| June 30, 2013 | -6.756M |
| March 31, 2013 | -6.088M |
| December 31, 2012 | -5.140M |
| September 30, 2012 | -4.985M |
| June 30, 2012 | -5.136M |
| March 31, 2012 | -5.455M |
| December 31, 2011 | -4.985M |
| September 30, 2011 | -4.316M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.247M
Minimum
Jun 2019
143.60M
Maximum
Dec 2023
68.16M
Average
54.30M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Pfizer Inc | 8.70B |
| Sarepta Therapeutics Inc | -500.99M |
| PTC Therapeutics Inc | -158.42M |
| Corcept Therapeutics Inc | 127.04M |
| Cytokinetics Inc | -414.33M |